2 options
Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer / prepared by Southern California-RAND Evidence-based Practice Center ; Ian Coulter, Mary Hardy, principal investigators.
Connect to full text Available online
View online- Format:
- Book
- Government document
- Series:
- Evidence report/technology assessment ; no. 78.
- AHRQ publication ; no. 03-E 030.
- Evidence report/technology assessment ; no. 78
- AHRQ publication ; no. 03-E 030
- Language:
- English
- Subjects (All):
- Cancer--Treatment.
- Cancer.
- Naltrexone.
- Alternative medicine.
- Therapeutics, Physiological.
- Outcome assessment (Medical care).
- Neoplasms--therapy.
- Outcome and Process Assessment, Health Care.
- Outcome Assessment, Health Care.
- Complementary Therapies.
- Immunotherapy--methods.
- Naltrexone--therapeutic use.
- Treatment Outcome.
- Medical Subjects:
- Neoplasms--therapy.
- Naltrexone.
- Outcome and Process Assessment, Health Care.
- Outcome Assessment, Health Care.
- Complementary Therapies.
- Immunotherapy--methods.
- Naltrexone--therapeutic use.
- Treatment Outcome.
- Physical Description:
- 1 online resource.
- Place of Publication:
- [Rockville, Md.] : [Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services], [2003]
- Notes:
- Title from title screen (viewed Apr 12, 2004).
- Includes bibliographical references (pages 127-128).
- Other Format:
- Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer
- ISBN:
- 1587630826
- 9781587630828
- OCLC:
- 54934000
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.